Revvity (RVTY) Net Cash Flow Growth (1y) (2010 - 2026)
Revvity (RVTY) Net Cash Flow Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | -298.36% |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | -7,202.13% |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 665.15% |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 117.44% |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 722.22% |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | -58.16% |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | -320.00% |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | -1,722.22% |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | -273.33% |
| 10 | Revvity | 11.63 Bn | 10.77 Bn | 387.66 Mn | 8.91% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 5, 2026 | 8.91% |
| Dec 28, 2025 | 130.37% |
| Sep 28, 2025 | -190.34% |
| Jun 29, 2025 | -276.28% |
| Mar 30, 2025 | -148.02% |
| Dec 29, 2024 | -107.72% |
| Sep 29, 2024 | 157.61% |
| Jun 30, 2024 | 111.43% |
| Mar 31, 2024 | 136.78% |
| Dec 31, 2023 | 994.97% |
| Apr 2, 2023 | -327.75% |
| Apr 3, 2022 | -81.05% |
| Oct 3, 2021 | -777.31% |
| Jul 4, 2021 | -1,449.29% |
| Apr 4, 2021 | 4,323.07% |
| Jan 3, 2021 | 86.56% |
| Oct 4, 2020 | -86.70% |
| Jul 5, 2020 | 24.03% |
| Apr 5, 2020 | 145.87% |
| Dec 29, 2019 | -3,681.20% |